Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tricida
Tricida
Biotechs reveal layoffs, research revamps in third quarter earnings
Biotechs reveal layoffs, research revamps in third quarter earnings
BioPharma Dive
layoffs
Tricida
Freeline Therapeutics
Harpoon Therapeutics
Adamis Pharmaceuticals
Neoleukin
NexImmune
Flag link:
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
Endpoints
Tricida
chronic kidney disease
M&A
Flag link:
Tricida’s shares plunge as phase 3 fail seals fate of FDA-rejected kidney disease drug
Tricida’s shares plunge as phase 3 fail seals fate of FDA-rejected kidney disease drug
Fierce Biotech
Tricida
clinical trial
kidney disease
Veverimer
Flag link:
Tricida sinks as FDA rejection raises prospect of new trial
Tricida sinks as FDA rejection raises prospect of new trial
Fierce Biotech
Tricida
metabolic acidosis
chronic kidney disease
clinical trials
FDA
Veverimer
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials
Flag link:
It’s a record! Biotech IPO frenzy outpaces 2017 in half the time as 4 new arrivals on Nasdaq raise $556M
It’s a record! Biotech IPO frenzy outpaces 2017 in half the time as 4 new arrivals on Nasdaq raise $556M
Endpoints
biotech
IPOs
Tricida
Translate Bio
Forty Seven
Neon Therapeutics
Aquestive Therapeutics
Flag link:
The Biotech IPO Rush Continues With Four More Coming Soon
The Biotech IPO Rush Continues With Four More Coming Soon
CP Wire
biotech
IPOs
Neon Therapeutics
Forty Seven
Translate Bio
Tricida
Flag link:
The Biotech IPO Rush Continues With Four More Coming Soon
biotech
IPOs
Neon Therapeutics
Forty Seven
Translate Bio
Tricida
Flag link:
Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
CP Wire
Tricida
chronic kidney disease
metabolic acidosis
TRC101
Flag link:
Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
Tricida
chronic kidney disease
Flag link: